Namwiwat Medical Corporation PCL (BKK:NAM)
Thailand flag Thailand · Delayed Price · Currency is THB
4.320
+0.020 (0.47%)
Mar 7, 2025, 10:00 AM ICT

BKK:NAM Income Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,1141,1011,099995.36676.61
Other Revenue
16.662.320.99-2.22
Revenue
1,1311,1031,100995.36678.84
Revenue Growth (YoY)
2.54%0.25%10.55%46.63%-
Cost of Revenue
646.51620.7772.91654.73467.39
Gross Profit
484.53482.38327.45340.63211.45
Selling, General & Admin
255.54230.16103.39115.1865.31
Operating Expenses
255.54230.16103.39115.1865.31
Operating Income
228.99252.22224.06225.45146.14
Interest Expense
-12.68-15.73-12.99-14.03-12.46
Interest & Investment Income
-1.571.060.020.02
Earnings From Equity Investments
---0.55-0.27-11.4
Currency Exchange Gain (Loss)
--13.041.14-
Other Non Operating Income (Expenses)
15.641.65-8.14--
EBT Excluding Unusual Items
231.94239.71216.48212.3122.3
Gain (Loss) on Sale of Investments
----10.65
Gain (Loss) on Sale of Assets
-10.575.441.48-
Pretax Income
231.94250.28221.91213.78132.95
Income Tax Expense
49.1249.5346.244.122.51
Earnings From Continuing Operations
182.83200.75175.71169.68110.44
Minority Interest in Earnings
-1.96--4.971.39
Net Income
180.87200.75175.71174.65111.83
Net Income to Common
180.87200.75175.71174.65111.83
Net Income Growth
-9.90%14.25%0.61%56.18%-
Shares Outstanding (Basic)
700615262020
Shares Outstanding (Diluted)
700615262020
Shares Change (YoY)
13.90%2237.62%31.45%--
EPS (Basic)
0.260.336.688.735.59
EPS (Diluted)
0.260.336.688.735.59
EPS Growth
-20.90%-95.11%-23.46%56.18%-
Free Cash Flow
-42.62228.27-81.1693.61104.71
Free Cash Flow Per Share
-0.060.37-3.094.685.24
Dividend Per Share
-0.090---
Gross Margin
42.84%43.73%29.76%34.22%31.15%
Operating Margin
20.25%22.87%20.36%22.65%21.53%
Profit Margin
15.99%18.20%15.97%17.55%16.47%
Free Cash Flow Margin
-3.77%20.69%-7.38%9.40%15.42%
EBITDA
266.81274.5241.25239.88-
EBITDA Margin
23.59%24.89%21.92%24.10%-
D&A For EBITDA
37.8222.2817.1914.43-
EBIT
228.99252.22224.06225.45146.14
EBIT Margin
20.25%22.86%20.36%22.65%21.53%
Effective Tax Rate
21.18%19.79%20.82%20.63%16.93%
Revenue as Reported
1,1311,1151,111997.98678.84
Source: S&P Capital IQ. Standard template. Financial Sources.